<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03507426</url>
  </required_header>
  <id_info>
    <org_study_id>RBKIPEA</org_study_id>
    <nct_id>NCT03507426</nct_id>
  </id_info>
  <brief_title>Retrobulbar Block Versus Ketamine Infusion for Post-enucleation Analgesia</brief_title>
  <official_title>Retrobulbar Block Versus Ketamine Infusion as Adjuvants to General Anesthesia for Post-operative Pain Control After Enucleation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nazmy Edward Seif</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study compares the efficacy and safety of two techniques, retrobulbar block versus
      intra-operative ketamine infusion, for control of post-operative pain occurring in patients
      undergoing ocular enucleation or evisceration performed under general anesthesia.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 25, 2018</start_date>
  <completion_date type="Actual">March 31, 2020</completion_date>
  <primary_completion_date type="Actual">March 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to the first post-operative rescue analgesia.</measure>
    <time_frame>24 hours</time_frame>
    <description>Time (measured in minutes) elapsed till the patient requires to receive his first post-operative rescue analgesic dose.</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">45</enrollment>
  <condition>Enucleated; Eye</condition>
  <condition>Evisceration; Operation Wound</condition>
  <condition>Pain, Postoperative</condition>
  <arm_group>
    <arm_group_label>Retrobulbar group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Retrobulbar block</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ketamine group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intravenous analgesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>General anesthesia alone</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Retrobulbar block</intervention_name>
    <description>Patients will receive a single retrobulbar injection with 3-4ml of an equal mixture of Lidocaine 2% &amp; Bupivacaine 0.5% + Hyaluronidase (10 IU/ml), after induction of general anesthesia.</description>
    <arm_group_label>Retrobulbar group</arm_group_label>
    <other_name>Local analgesia</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Ketamine</intervention_name>
    <description>Patients will receive a 0.5 mg/kg bolus followed by an infusion of 0.25 mg/kg/h of intravenous Ketamine, after induction of general anesthesia.</description>
    <arm_group_label>Ketamine group</arm_group_label>
    <other_name>IV analgesia</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Ocular enucleation candidate patients

          -  Ocular evisceration candidate patients

        Exclusion Criteria:

          -  Any condition contra-indicating general or local anesthesia

          -  Allergy to any of the drugs used during the procedure
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ahmed M El-Badawy, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Kasr Al-Ainy Hospital, Cairo University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Nazmy E Seif, MD</last_name>
    <role>Study Director</role>
    <affiliation>Kasr Al-Ainy Hospital, Cairo University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Kasr Al-Ainy Hospital, Cairo University</name>
      <address>
        <city>Cairo</city>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>April 15, 2018</study_first_submitted>
  <study_first_submitted_qc>April 24, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 25, 2018</study_first_posted>
  <last_update_submitted>July 13, 2020</last_update_submitted>
  <last_update_submitted_qc>July 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 14, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Nazmy Edward Seif</investigator_full_name>
    <investigator_title>Clinical Professor</investigator_title>
  </responsible_party>
  <keyword>Retrobulbar block</keyword>
  <keyword>Ketamine</keyword>
  <keyword>Ocular enucleation</keyword>
  <keyword>Analgesia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ketamine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

